Abstract
Introduction: In pediatric kidney patients, where clinical presentation is often not fully developed, and renal biopsy is too risky or inconclusive, it may be difficult to establish the underlying pathology. In cases such as these, genetic diagnosis may be used to guide treatment, prognosis, and counseling. Given the large number of genes involved in kidney disease, introducing next-generation sequencing with extended gene panels as part of the diagnostic algorithm presents a viable solution. Methods: A cohort of 87 consecutive independent cases (83 children and 4 terminated pregnancies) with renal disease was recruited. Exome sequencing with MiSeq or NovaSeq 6000 (Illumina) platforms and analysis of extended gene panels were used for genetic testing. Results: Depending on the presenting pathology, the cases were grouped as patients with glomerular disease, ciliopathies, congenital anomalies, renal electrolyte imbalances, and chronic/acute kidney disease. The overall diagnostic yield was approximately 42% (37 out of 87), with most disease-causing mutations found in COL4A3, COL4A4, COL4A5, and PKHD1 genes. A change or clarification of preliminary diagnosis or adjustment of initial treatment plan based on the results of the genetic testing was made for approximately one-third of the children with meaningful genetic findings (11 out of 37). Discussion: Our results prove the value of targeted exome sequencing as a non-invasive, versatile, and reliable diagnostic tool for pediatric renal disease patients. Providing genetic diagnosis will help for a better understanding of disease etiology and will give the basis for optimal clinical management and insightful genetic counseling.
Journal Section:
Experimental Nephrology and Genetics: Research Article
References
1.
Vivante
A
, Hildebrandt
F
. Exploring the genetic basis of early-onset chronic kidney disease
. Nat Rev Nephrol
. 2016
;12
(3
):133
–46
. .2.
Chen
J
, Lin
F
, Zhai
Y
, Wang
C
, Wu
B
, Ma
D
, et al. Diagnostic and clinical utility of genetic testing in children with kidney failure
. Pediatr Nephrol
. 2021
;36
(11
):3653
–62
. .3.
Vaisitti
T
, Sorbini
M
, Callegari
M
, Kalantari
S
, Bracciama
V
, Arruga
F
, et al. Clinical exome sequencing is a powerful tool in the diagnostic flow of monogenic kidney diseases: an Italian experience
. J Nephrol
. 2021
;34
(5
):1767
–81
. .4.
Richards
S
, Aziz
N
, Bale
S
, Bick
D
, Das
S
, Gastier-Foster
J
, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology
. Genet Med
. 2015
;17
(5
):405
–24
. .5.
Bisceglia
L
, Calonge
MJ
, Dello Strologo
L
, Rizzoni
G
, de Sanctis
L
, Gallucci
M
, et al. Molecular analysis of the cystinuria disease gene: identification of four new mutations, one large deletion, and one polymorphism
. Hum Genet
. 1996
;98
(4
):447
–51
. .6.
Károlyi
L
, Konrad
M
, Köckerling
A
, Ziegler
A
, Zimmermann
DK
, Roth
B
, et al. Mutations in the gene encoding the inwardly-rectifying renal potassium channel, ROMK, cause the antenatal variant of Bartter syndrome: evidence for genetic heterogeneity. International Collaborative Study Group for Bartter-like Syndromes
. Hum Mol Genet
. 1997
;6
(1
):17
–26
.7.
Weber
S
, Hoffmann
K
, Jeck
N
, Saar
K
, Boeswald
M
, Kuwertz-Broeking
E
, et al. Familial hypomagnesaemia with hypercalciuria and nephrocalcinosis maps to chromosome 3q27 and is associated with mutations in the PCLN-1 gene
. Eur J Hum Genet
. 2000
;8
(6
):414
–22
. .8.
Ji
W
, Foo
JN
, O’Roak
BJ
, Zhao
H
, Larson
MG
, Simon
DB
, et al. Rare independent mutations in renal salt handling genes contribute to blood pressure variation
. Nat Genet
. 2008
;40
(5
):592
–9
. .9.
Schlingmann
KP
, Kaufmann
M
, Weber
S
, Irwin
A
, Goos
C
, John
U
, et al. Mutations in CYP24A1 and idiopathic infantile hypercalcemia
. N Engl J Med
. 2011
;365
(5
):410
–21
. .10.
Streeten
EA
, Zarbalian
K
, Damcott
CM
. CYP24A1 mutations in idiopathic infantile hypercalcemia
. N Engl J Med
. 2011
;365
(18
):1741
–3
; author reply 42-3. .11.
Mohebbi
N
, Vargas-Poussou
R
, Hegemann
SC
, Schuknecht
B
, Kistler
AD
, Wuthrich
RP
, et al. Homozygous and compound heterozygous mutations in the ATP6V1B1 gene in patients with renal tubular acidosis and sensorineural hearing loss
. Clin Genet
. 2013
;83
(3
):274
–8
. .12.
Savige
J
, Storey
H
, Watson
E
, Hertz
JM
, Deltas
C
, Renieri
A
, et al. Consensus statement on standards and guidelines for the molecular diagnostics of Alport syndrome: refining the ACMG criteria
. Eur J Hum Genet
. 2021
;29
(8
):1186
–97
. .13.
Majmundar
AJ
, Buerger
F
, Forbes
TA
, Klambt
V
, Schneider
R
, Deutsch
K
, et al. Recessive NOS1AP variants impair actin remodeling and cause glomerulopathy in humans and mice
. Sci Adv
. 2021
;7
(1
):eabe1386
. .14.
Fargue
S
, Lewin
J
, Rumsby
G
, Danpure
CJ
. Four of the most common mutations in primary hyperoxaluria type 1 unmask the cryptic mitochondrial targeting sequence of alanine:glyoxylate aminotransferase encoded by the polymorphic minor allele
. J Biol Chem
. 2013
;288
(4
):2475
–84
. .15.
Claus
LR
, Snoek
R
, Knoers
N
, van Eerde
AM
. Review of genetic testing in kidney disease patients: diagnostic yield of single nucleotide variants and copy number variations evaluated across and within kidney phenotype groups
. Am J Med Genet C Semin Med Genet
. 2022
;190
(3
):358
–76
. .16.
Gbadegesin
RA
, Winn
MP
, Smoyer
WE
. Genetic testing in nephrotic syndrome--challenges and opportunities
. Nat Rev Nephrol
. 2013
;9
(3
):179
–84
. .17.
Preston
R
, Stuart
HM
, Lennon
R
. Genetic testing in steroid-resistant nephrotic syndrome: why, who, when and how
. Pediatr Nephrol
. 2019
;34
(2
):195
–210
. .18.
Trautmann
A
, Vivarelli
M
, Samuel
S
, Gipson
D
, Sinha
A
, Schaefer
F
, et al. IPNA clinical practice recommendations for the diagnosis and management of children with steroid-resistant nephrotic syndrome
. Pediatr Nephrol
. 2020
;35
(8
):1529
–61
. .19.
Jung
J
, Lee
JH
, Seo
GH
, Keum
C
, Kang
HG
, Cho
H
, et al. Genetic diagnosis of kidney disease by whole exome sequencing and its clinical application
. Clin Genet
. 2023
;104
(3
):298
–312
. .20.
Riedhammer
KM
, Comic
J
, Tasic
V
, Putnik
J
, Abazi-Emini
N
, Paripovic
A
, et al. Exome sequencing in individuals with congenital anomalies of the kidney and urinary tract (CAKUT): a single-center experience
. Eur J Hum Genet
. 2023
;31
(6
):674
–80
. .21.
Cantsilieris
S
, Nelson
BJ
, Huddleston
J
, Baker
C
, Harshman
L
, Penewit
K
, et al. Recurrent structural variation, clustered sites of selection, and disease risk for the complement factor H (CFH) gene family
. Proc Natl Acad Sci USA
. 2018
;115
(19
):E4433
–42
. .22.
Gale
DP
, de Jorge
EG
, Cook
HT
, Martinez-Barricarte
R
, Hadjisavvas
A
, McLean
AG
, et al. Identification of a mutation in complement factor H-related protein 5 in patients of Cypriot origin with glomerulonephritis
. Lancet
. 2010
;376
(9743
):794
–801
. .23.
Malik
TH
, Lavin
PJ
, Goicoechea de Jorge
E
, Vernon
KA
, Rose
KL
, Patel
MP
, et al. A hybrid CFHR3-1 gene causes familial C3 glomerulopathy
. J Am Soc Nephrol
. 2012
;23
(7
):1155
–60
. .24.
Ravindra
VM
, Karsy
M
, Schmidt
RH
, Taussky
P
, Park
MS
, Bollo
RJ
. Rapid de novo aneurysm formation after clipping of a ruptured middle cerebral artery aneurysm in an infant with an MYH11 mutation
. J Neurosurg Pediatr
. 2016
;18
(4
):463
–70
. .25.
Keylock
A
, Hong
Y
, Saunders
D
, Omoyinmi
E
, Mulhern
C
, Roebuck
D
, et al. Moyamoya-like cerebrovascular disease in a child with a novel mutation in myosin heavy chain 11
. Neurology
. 2018
;90
(3
):136
–8
. .26.
Gigante
M
, Caridi
G
, Montemurno
E
, Soccio
M
, d’Apolito
M
, Cerullo
G
, et al. TRPC6 mutations in children with steroid-resistant nephrotic syndrome and atypical phenotype
. Clin J Am Soc Nephrol
. 2011
;6
(7
):1626
–34
. .27.
Martin
P
, Heiskari
N
, Zhou
J
, Leinonen
A
, Tumelius
T
, Hertz
JM
, et al. High mutation detection rate in the COL4A5 collagen gene in suspected Alport syndrome using PCR and direct DNA sequencing
. J Am Soc Nephrol
. 1998
;9
(12
):2291
–301
. .28.
Zurowska
AM
, Bielska
O
, Daca-Roszak
P
, Jankowski
M
, Szczepanska
M
, Roszkowska-Bjanid
D
, et al. Mild X-linked Alport syndrome due to the COL4A5 G624D variant originating in the Middle Ages is predominant in Central/East Europe and causes kidney failure in midlife
. Kidney Int
. 2021
;99
(6
):1451
–8
. .29.
Tsukaguchi
H
, Sudhakar
A
, Le
TC
, Nguyen
T
, Yao
J
, Schwimmer
JA
, et al. NPHS2 mutations in late-onset focal segmental glomerulosclerosis: R229Q is a common disease-associated allele
. J Clin Invest
. 2002
;110
(11
):1659
–66
. .30.
Tory
K
, Menyhard
DK
, Woerner
S
, Nevo
F
, Gribouval
O
, Kerti
A
, et al. Mutation-dependent recessive inheritance of NPHS2-associated steroid-resistant nephrotic syndrome
. Nat Genet
. 2014
;46
(3
):299
–304
. .31.
Miko
A
, K Menyhárd
D
, Kaposi
A
, Antignac
C
, Tory
K
. The mutation-dependent pathogenicity of NPHS2 p.R229Q: a guide for clinical assessment
. Hum Mutat
. 2018
;39
(12
):1854
–60
. .32.
Dodova
RI
, Mitkova
AV
, Dacheva
DR
, Hadjo
LB
, Vlahova
AI
, Taushanova-Hadjieva
MS
, et al. Erratum to: spectrum and frequencies of BRCA1/2 mutations in Bulgarian high risk breast cancer patients
. BMC Cancer
. 2017
;17
(1
):195
. .33.
Stokman
MF
, Renkema
KY
, Giles
RH
, Schaefer
F
, Knoers
NV
, van Eerde
AM
. The expanding phenotypic spectra of kidney diseases: insights from genetic studies
. Nat Rev Nephrol
. 2016
;12
(8
):472
–83
. .© 2024 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2024
You do not currently have access to this content.
